BOSTON: In the white matter of the brain in particular, large differences can be measured between the brains of people with Alzheimer’s disease and those with the behavioral variant frontotemporal dementia.

The aim of the research was to detect changes in the brain as early Read More »

DALLAS: Designers, coders, hackers and researchers are coming together for an event aimed at exploring how digital technologies could support and improve dementia care.

Create-4-Dementia is the first public event of the Social Computing and Mental Health Research Network…

Full story covered in the Dementia

MIAMI: Researchers have created a new and much-anticipated data resource to help establish how differences in an individual’s genomic make-up can affect gene activity and contribute to disease.

The new resource will enable scientists to examine the underlying genomics of many different human tissues and Read More »

PHILADELPHIA: At World Medical Innovation Forum in Boston, Biogen CEO George Scangos said that the company has decided to commit $2.5 billion to develop the drug for Alzheimer’s. This amount is inclusive of the R&D through 2 phase III trials and new manufacturing facility in Read More »